Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    PARKINSON DISEASE 12
Show Display Options
Rank Status Study
21 Completed
Has Results
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump;   Device: PEG tube;   Device: J-tube
22 Completed
Has Results
Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
Conditions: Parkinson Disease;   Idiopathic Parkinson Disease;   Idiopathic Parkinson's Disease
Interventions: Drug: Preladenant;   Drug: Placebo
23 Not yet recruiting An Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Interventions: Drug: ABT-SLV187;   Drug: optimized antiparkinsonian treatment
24 Completed The Effects of the Hopeful Outdoor Parkinson Exercise (HOPE) Program on Improving Balance Performance in Parkinsonian Non-fallers and Single Fallers
Condition: Parkinson's Disease
Interventions: Behavioral: an 8-week blended indoor-outdoor exercise program;   Behavioral: an 8-week upper limb and hand exercise program
25 Completed
Has Results
Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms
Conditions: Parkinson Disease;   Depression
Interventions: Drug: Pramipexole;   Other: Placebo
26 Completed
Has Results
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Conditions: Dyskinesias;   Parkinson's Disease;   Severe Motor Fluctuations
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump;   Device: PEG tube;   Device: J-tube
27 Completed Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders
Interventions: Drug: AFQ056;   Drug: Placebo
28 Completed Dyskinesia in Parkinson's Disease (Study P04501)
Conditions: Parkinson Disease;   Movement Disorders;   Central Nervous System Diseases;   Neurodegenerative Diseases;   Brain Diseases
Interventions: Drug: SCH 420814;   Drug: Placebo;   Drug: L-dopa;   Drug: Other Parkinson's Disease treatments
29 Completed COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
Conditions: Mild Cognitive Impairment;   Dementia;   Hypoxia;   Hyperhomocysteinemia;   Vitamin B 12 Deficiency;   Iron Deficiency;   Anemia;   TBI;   Neurodegenerative Disorders;   Alzheimer's Disease;   Vascular Dementia;   Brain Injuries;   Tauopathies;   Parkinson's Disease;   Lewy Body Dementia;   Frontotemporal Dementia;   TDP-43 Proteinopathies
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-29) Next Page   
Study has passed its completion date and status has not been verified in more than two years.